A greater understanding of the biology of mesothelioma has led to new clinical trials testing immunotherapies and targeted drugs against the disease.
In this week's cancer news there's Brexit plans, viruses being used as treatments, and disagreements over screening for prostate cancer.
Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment
A year on from a big data report and some hospitals have changed how they discuss some aspects of treatment, including palliative care.
New research by our scientists may have identified a new way to predict which patients might benefit from certain immunotherapies, and those who likely won’t.
Scientists have discovered a new type of immune cell that could predict which lung cancer patients will benefit most from immunotherapy treatment.
Targeted treatment up front improves survival for advanced prostate cancer, and we predict a change in thinking for precision cancer medicine.
Using two immunotherapy drugs together could help treat some patients with an aggressive form of breast cancer, according to an Australian study.
A researcher explains an early stage clinical trial testing the potential of a new type of immunotherapy to treat neuroblastoma.